ENTITY

MagForce AG (MF6 GR)

22
Analysis
Health CareGermany
Magforce AG develops medical technologies. The Company specializes in nanocancer therapy for treatment of cancerous tumors. Magforce's treatment uses nanoparticles containing ironoxide, which are injected into solid tumors in a procedure similar to a biopsy.
more
bullishMagForce AG
31 Oct 2022 19:39Issuer-paid

MagForce - Termination of coverage

Edison Investment Research is terminating coverage on Mercia Asset Management (MERC), Bloc Ventures (unlisted), YOC (YOC.DE), Genuit Group (GEN),...

Share
bullishMagForce AG
10 Nov 2021 18:40Issuer-paid

MagForce - Primed to execute on its growth strategy

MagForce continues to pursue its two-pillarMagForce continues to pursue its two-pillar strategy to drive uptake of its nanotechnology-based thermal...

Share
bullishMagForce AG
10 Nov 2021 15:28Issuer-paid

MagForce - Primed to execute on its growth strategy

MagForce continues to pursue its two-pillar strategy to drive uptake of its nanotechnology-based thermal ablation treatment, NanoTherm. In the...

Share
bullishMagForce AG
14 Jul 2021 15:54Issuer-paid

MagForce - Time to capitalise on growth potential

In FY20, MagForce made steady progress in its strategy to drive uptake of its nanotechnology-based thermal ablation treatment, NanoTherm. In...

Share
bullishMagForce AG
14 Oct 2020 21:22Issuer-paid

MagForce - Striding towards major inflection pointsDE000A0HGQF5magforce141020qv.pdf

MagForce, a pioneer in nanotechnology-based cancer treatments, is making steady progress with its strategy to drive the uptake of its thermal...

Share
No more insights
x